A5031230043- Dementia and Cognitive Impairment Research
- EEG and Brain-Computer Interfaces
- Schizophrenia research and treatment
- Amyotrophic Lateral Sclerosis Research
- Palliative Care and End-of-Life Issues
- Intergenerational Family Dynamics and Caregiving
- Patient-Provider Communication in Healthcare
- Diet and metabolism studies
- Alzheimer's disease research and treatments
- Family Support in Illness
- Risk and Safety Analysis
- Family and Disability Support Research
- Historical Psychiatry and Medical Practices
- Psychological and Temporal Perspectives Research
- Mental Health Treatment and Access
- Traffic Prediction and Management Techniques
- Spaceflight effects on biology
- Maritime Navigation and Safety
- Muscle activation and electromyography studies
- Bipolar Disorder and Treatment
- Psychiatric care and mental health services
- Optical Imaging and Spectroscopy Techniques
- Patient Dignity and Privacy
- Mental Health and Patient Involvement
- Neuroscience and Music Perception
Temple University Hospital
2025
University of Michigan
2020-2023
University of Illinois Urbana-Champaign
2022
Michigan Department of Health and Human Services
2020-2021
Temple University
2021
Drexel University
2018
State Street (United States)
2018
National Institute of Mental Health
2011
<sec> <title>BACKGROUND</title> Youth are increasingly experiencing psychological distress. Schools ideal settings for disseminating mental health support, but they often insufficiently resourced to do so. Digital tools represent a unique avenue address this gap. The Alongside digital program is one such tool, intended as universal prevention and early intervention. platform includes social-emotional learning self-help wellness features well an AI-powered chatbot designed build coping...
Informal caregivers for persons with dementia frequently report needing assistance, yet formal support service use has been low. To better understand factors associated use, correlates of self-reported (e.g., groups, family mediation, leave, classes/trainings, and respite care) among were assessed. The National Poll on Healthy Aging conducted a nationally representative web-based survey adults aged 50–80 (N = 2,131) using Ispos' KnowledgePanel®; 148 reported caregiving an adult memory loss...
Abstract Introduction The safety of predicting conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia using apolipoprotein E ( APOE ) genotyping is unknown. Methods We randomized 114 individuals with MCI receive estimates 3‐year risk AD informed by (disclosure arm) or not (non‐disclosure in a non‐inferiority clinical trial. Primary outcomes were anxiety and depression scores. Secondary included other psychological measures. Results Upper confidence limits for...
Abstract Background/Objectives Disclosure of Alzheimer's disease (AD) risk information to cognitively unimpaired older adults may become more common if preclinical AD is shown be identifiable and amenable treatment. Little, however, known about how families will react this information. Design Setting Semi‐structured telephonic interviews. Participants Seventy study partners (mean age = 68 [±11]; 50% female; 70% spouses/significant others; 18% children, siblings; 12% friends) who learned a...
The author reviews the leadership changes that have taken place in mental health organizations and factors influenced these as field has developed. administrators of early hospitals were physicians laymen. By mid 1840s, physician-administrator had become dominant, but this changed with social values 1960s growth community centers. Most recent been movement into positions by professional without clinical training. suggests leaders 1980s must understand administration is substantially modified...
Background: Progressive cortical gray matter (GM) abnormalities are an established feature of schizophrenia and more pronounced in rare, severe, treatment refractory childhood-onset (COS) cases. The effect sex on brain development is poorly understood studies to date have produced inconsistent results. >Methods: Using the largest longitudinal sample COS cases (n = 104, scans 249, Male/Female [M/F] 57/47), we compared differences with a matched typically developing children 244, M/F determine...
Cognitive impairment in amyotrophic lateral sclerosis (ALS) is associated with cortical changes beyond the motor cortex. The overall goal of this project to determine if task induced hemodynamic detected by functional near infrared (fNIR) spectroscopy from anterior prefrontal cortex (PFC) has discriminant validity across ALS (n = 17) patients and matching healthy controls. experimental protocol was composed King-Devick Test, Number Interference Test a Continuous Performance targeting range...
<h3>Background:</h3> Youth are increasingly upholding significant caregiving responsibilities. These responsibilities can have emotional, educational, and professional impacts on youth young adults. And yet, policies resources focus adult caregivers limited in supporting caregivers. The purpose of this study was to describe the different types support that identify as being important prepare take care an relative. <h3>Methods:</h3> We conducted open-ended, text-message based poll ages 14 24...
Objective: There are many potential benefits of early identification those with Alzheimer’s disease (AD), including more opportunity for intervention to slow AD progression (e.g., treatment, lifestyle changes, etc.) and plan the future. Positron emission tomography (PET) scans abnormal amyloid tau commonly conducted in research settings. Despite strong interest learning biomarker results, participants rarely receive their data, part due concern about possibility undue distress based on...
Abstract Objective: In the absence of treatments to halt or reverse symptoms Alzheimer's disease, early detection may extend window for meaningful treatment, advanced planning, and coping. Positron emission tomography (PET) scans amyloid tau are validated biomarkers AD, yet results rarely disclosed participants due concerns about negative impacts. While prior studies suggest limited anxiety, depression, suicidality following biomarker disclosure, no study date has examined broader...
Abstract Background Alzheimer’s disease (AD) biomarker disclosure is a potential avenue for tailoring person‐centered care patients and families targeting known health disparities. However, cannot take one‐size‐fits‐all approach. It critical to understand whether older adults with without cognitive impairment (i.e., mild (MCI)) their partners are interested in engaging disclosure, what perceived benefits risks exist, as function of race, social determinants, clinical status. Method 57...
Abstract Background Older adults are highly interested in learning their Alzheimer’s disease (AD) positron emission tomography (PET) amyloid‐beta (Aβ) and tau results. However, knowledge about the meaning, uses, risks of personal biomarker results is variable. Tools needed to assess decisional capacity prior disclosure, particularly for individuals with cognitive impairment. Methods 30 participants (46.7% female; 93.3% white, age = 71.9±7.14 years) diagnosed either mild impairment (MCI;...